Johnson & Johnson (NYSE: JNJ) on Tuesday, plunged -0.31% from the previous trading day, before settling in for the closing price of $207.56. Within the past 52 weeks, JNJ’s price has moved between $140.68 and $215.18.
Healthcare Sector giant saw their annual sales surged by 0.55% over the last five years. The company achieved an average annual earnings per share of 8.82%. With a float of $2.41 billion, this company’s outstanding shares have now reached $2.41 billion.
Johnson & Johnson (JNJ) Insider Activity
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Johnson & Johnson is 0.12%, while institutional ownership is 74.47%. The most recent insider transaction that took place on Nov 26 ’25, was worth 257,688. In this transaction Director of this company bought 1,250 shares at a rate of $206.15, taking the stock ownership to the 1,849 shares. Before that another transaction happened on Nov 26 ’25, when Company’s 10% Owner sold 6,337 for $10.03, making the entire transaction worth $63,560. This insider now owns 4,040,861 shares in total.
Johnson & Johnson (JNJ) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 2.04 earnings per share (EPS) for the period topping the consensus outlook (set at 2.01) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.74 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.52% during the next five years compared to 0.55% growth over the previous five years of trading.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Johnson & Johnson (JNJ) is currently performing well based on its current performance indicators. A quick ratio of 0.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.41. Likewise, its price to free cash flow for the trailing twelve months is 25.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 10.36, a number that is poised to hit 2.52 in the next quarter and is forecasted to reach 11.53 in one year’s time.
Technical Analysis of Johnson & Johnson (JNJ)
Analysing the last 5-days average volume posted by the [Johnson & Johnson, JNJ], we can find that recorded value of 4.01 million was lower than the volume posted last year of 8.85 million. As of the previous 9 days, the stock’s Stochastic %D was 39.33%.
During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 81.53%, which indicates a significant increase from 44.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.41 in the past 14 days, which was higher than the 2.78 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $199.63, while its 200-day Moving Average is $173.70. Now, the first resistance to watch is $207.56. This is followed by the second major resistance level at $208.21. The third major resistance level sits at $208.73. If the price goes on to break the first support level at $206.39, it is likely to go to the next support level at $205.87. Should the price break the second support level, the third support level stands at $205.22.
Johnson & Johnson (NYSE: JNJ) Key Stats
Market capitalization of the company is 498.51 billion based on 2,409,295K outstanding shares. Right now, sales total 88,821 M and income totals 14,066 M. The company made 23,993 M in profit during its latest quarter, and 5,152 M in sales during its previous quarter.
